Poniard Pharmaceuticals, Inc.
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products. The company is currently focusing on developing picoplatin, a new and differentiated platinum-based chemotherapeutic agent that is used in the clinical development for multiple cancer indications, treatment combinations and by two routes of administration. It operates through Cancer Therapeutics Development segment. The company was founded in 1984 and is headquartered in Seattle, WA.